Lori McNeill's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 4,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Hol... | Lori McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 4,000 | 4,394 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | McNeill Lori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 373 | 394 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Lori McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 3,770 | 3,770 | - | - | Common Stock |